Last edition
News about "TRANQUILLO trial"
Pfizer Reports Positive Phase 3 Results for LITFULO in Vitiligo
Pfizer's phase 3 studies showed LITFULO significantly improved facial and total repigmentation in patients with nonsegmental vitiligo versus placebo.
TRANQUILLO Trial | 31/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members